Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
---|
08/14/2003 | CA2474214A1 Novel aryl- and heteroarylpiperazines |
08/14/2003 | CA2473505A1 Novel bicyclic hydroxamates as inhibitors of histone deacetylase |
08/13/2003 | EP1334719A2 Pentafluorobenzenesulfonamides and analogs |
08/13/2003 | EP1334098A2 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders |
08/13/2003 | EP1334085A1 Sulfamides as gamma-secretase inhibitors |
08/13/2003 | EP1334084A2 Phosgene-free process for preparing carbamates |
08/13/2003 | EP1334083A2 1,4-disubstituted benzenes as insecticides |
08/13/2003 | EP1333795A1 Novel coupler for use in oxidative hair dyeing |
08/13/2003 | EP1242427B1 Novel piperidine and piperazine derivatives as p2x7 receptor antagonists |
08/13/2003 | EP0946539B1 Sulphonamide derivatives, process for their preparation, and their use as medicaments |
08/13/2003 | EP0946504B1 Compounds useful for perhalogenoalkylation, reagent for implementing these compounds and synthesis method for obtaining these compounds |
08/13/2003 | CN1436170A Vitamin D derivs. |
08/12/2003 | US6605677 Olefin polymerization processes using supported catalysts |
08/12/2003 | US6605635 N-substituted benzyl or phenyl aromatic sulfamides compounds and the use thereof |
08/12/2003 | US6605632 Affinity for melatonin receptors |
08/12/2003 | US6605626 Antithrombotic agents |
08/12/2003 | US6605608 Amino acid derivatives and drugs containing the same as the active ingredient |
08/12/2003 | US6605124 Naphthol hair dyes for keratinous fibers |
08/07/2003 | WO2003064402A1 Treatment of male sexual dysfunction |
08/07/2003 | WO2003064378A2 Novel compounds that inhibit factor xa activity |
08/07/2003 | WO2003064369A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
08/07/2003 | WO2003063852A1 Therapeutic agent for urinary incontinence |
08/07/2003 | WO2003063797A2 Cycloalkyl inhibitors of potassium channel function |
08/07/2003 | US20030149083 For therapy of inflammatory diseases, rheumatoid arthritis, inflammatory bowel diseases, systemic erythematodes, multiple sclerosis, Sjogren's syndrome, asthma, psoriasis, allergy, diabetes, cardiovascular diseases, arterial sclerosis |
08/07/2003 | US20030149055 Bicyclic compounds as inhibitors of chemokine binding to US28 |
08/07/2003 | US20030149047 Novel compounds |
08/07/2003 | US20030149021 For therapy of cancer, as antibacterial, as insecticide |
08/07/2003 | US20030149020 For therapy or prophylaxis of obesity, type II diabetes, or disorders of the central nervous system |
08/07/2003 | US20030149019 For therapy or prophylaxis of obesity, type II diabetes, or disorders of the central nervous system |
08/07/2003 | US20030149015 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives |
08/07/2003 | US20030147845 O2-arylated or O2-glycosylated 1-substituted diazen-1-ium-1,2-diolates and O2-substituted 1-[(2-carboxylato) pyrrolidin-1-yl]diazen-1-ium-1,2-diolates |
08/07/2003 | CA2474590A1 Treatment of male sexual dysfunction |
08/07/2003 | CA2474451A1 Cycloalkyl inhibitors of potassium channel function |
08/07/2003 | CA2473164A1 Novel compounds that inhibit factor xa activity |
08/07/2003 | CA2473162A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
08/06/2003 | EP1333024A1 Peptide derivatives and their pharmaceutically acceptable salts, processes for preparation of both, and use thereof |
08/06/2003 | EP1332138A1 Radiopharmaceuticals for diagnosing alzheimer's disease |
08/06/2003 | EP1332127A2 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis |
08/06/2003 | CN1434827A 新的哌啶和哌嗪衍生物 The new piperidine and piperazine derivatives |
08/06/2003 | CN1434819A 4-phenyl-peiperazinyl,-piperidinyl and -Tetrahydropyridyl derivatives |
08/06/2003 | CN1434813A Pyrrolidine derivatives cyclic AMP-specific phosphodiesterase inhibitors |
08/06/2003 | CN1434796A Acylphenylurea derivatives, a process for their preparation and their use as pharmaceuticals |
08/06/2003 | CN1434724A Remedies and/or preventives for nervous system disorders |
08/06/2003 | CN1434034A Amidemercaptan and thioderivative thereof |
08/06/2003 | CN1117095C Antibacterial substituted 7-2cylamino-3(methylhydrazono) methyl-cephalosponins and intermediates |
08/05/2003 | US6603022 Reacting Lovastatin with a secondary amine under suitable conditions to form the corresponding amide intermediate, methylating the C-8 butyrate side chain, hydrolyzing to free carboxylic acid; lactonization |
08/05/2003 | US6603003 Method for the preparation of piperazine and its derivatives |
08/05/2003 | US6602869 Compounds derived from benzoic acid esters, composition containing said compounds and use thereof |
07/31/2003 | WO2003062228A1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatites c virus infection |
07/31/2003 | WO2003062192A1 Cycloalkyl ketoamides derivatives useful as cathepsin k inhibitors |
07/31/2003 | WO2003061660A1 Melanocortin receptor agonists |
07/31/2003 | WO2003041649A3 Cyanoalkylamino derivatives as protease inhibitors |
07/31/2003 | WO2003002596A3 Use of dipeptidyl peptidase iv inhibitors as therapeutics for neurological disorders |
07/31/2003 | WO2002020500A3 Materials and methods to potentiate cancer treatment |
07/31/2003 | US20030144505 Novel compounds |
07/31/2003 | US20030144328 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
07/31/2003 | US20030144323 Phenylalkynes |
07/31/2003 | US20030144299 Method of treating depression with delta receptor agonist compounds |
07/31/2003 | US20030144292 Protease inhibitors such as N-((4'-Methoxy-(1,1'-biphenyl)-4-yl)-sulfonyl-N-methyl-amino)-(4 -hydroxycyclohexan-1-yl)-acetic acid for prophylaxis of neurodegenerative diseases, vision defects, skin disorders or as antiinflammatory agents |
07/31/2003 | US20030144291 Substituted indan derivatives |
07/31/2003 | US20030144285 Cholinergic agents such as 4-Butyl-1-(4-phenyl-4-oxo-1-butyl) piperidine, administered as cognition activators and for prophylaxis of vision defects |
07/31/2003 | US20030144275 Decyclization of oxabenzonorbornadienes or azabicyclic compounds in the presence of catalysts to form naphthalenes, such as 2-methoxy-1,2-dihydronaphthalen-1-ol, used as analgesics, anticarcinogens or viricides; catalysis |
07/31/2003 | US20030144272 Heterocyclic amines such as 2-(2-(N-Methylsulfamoyl)-4-methoxy -phenyl)-N-methyl-N-((1S)-1-phenyl-2-((1-pyrrolidinyl)ethyl)) acetamide, administered as analgesics |
07/31/2003 | US20030144267 Novel compounds |
07/31/2003 | US20030144265 HIV protease inhibitors based on amino acid derivatives |
07/31/2003 | US20030144261 A cyclic peptide useful for treating eating disorder and diabetes |
07/31/2003 | US20030144234 Administering a cathepsin modulator or enzyme inhibitor, select from a mRNA or a protein; gene expression inhibition, analgesics |
07/31/2003 | US20030143559 A modified estrogen receptor alpha ligand binding domain containing an amino acid modification in region 1, at region 2, or atleast one amino acid modifiation in both of regions, and these domain interacts with a nonendogenous ligand |
07/31/2003 | US20030143481 Image forming material and ammonium compound |
07/31/2003 | US20030140431 3-(2,5-Diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds |
07/31/2003 | CA2473036A1 Melanocortin receptor agonists |
07/30/2003 | EP1330233A1 Method of treating stroke |
07/30/2003 | EP1187817B1 Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same |
07/30/2003 | EP0592439B1 Aminosulfonyl carbamates |
07/30/2003 | CN1433411A Chemical compounds |
07/30/2003 | CN1433407A Bis-arylsulfones |
07/30/2003 | CN1433396A Pharmaceutical compounds |
07/29/2003 | US6600072 Substituted 1-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic , and medicament containing them |
07/29/2003 | US6599942 Method of lowering LDL cholesterol and Lipoprotein a levels in mammals using such compounds |
07/29/2003 | US6599932 Highly selective in killing tumor cells but not normal cells |
07/29/2003 | US6599921 Antiproliferative agents against estrogen-dependent cancer cells dibenzothiopyran, dibenzopyran and phenanthrene derivatives |
07/29/2003 | US6599920 Antiestrogenic compound having fewer or no estrogen agonist properties on reproductive tissues |
07/29/2003 | US6599904 Sulphonamide derivatives, process for their preparation, and their use as medicaments |
07/29/2003 | US6599903 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
07/29/2003 | CA2188690C Selective thrombin inhibitors |
07/24/2003 | WO2003059894A1 Novel antibacterial compounds:process for their preparation and pharmaceutical compositions containing them. |
07/24/2003 | WO2003059873A1 Potassium channel modulators |
07/24/2003 | WO2003059353A1 Tyrosyl derivatives and their use as p2x7 receptor modulators |
07/24/2003 | WO2003059335A1 Phenyl sulfoxides and phenyl sulfones |
07/24/2003 | WO2003059265A2 Compositions and methods for treating heart failure |
07/24/2003 | US20030139605 Antiproliferative agents, treating or preventing osteoporosis, inflammation, and angiogenesis disorders, treating liver cancer |
07/24/2003 | US20030139449 Anxiolytic agents; psychological disorders; cognition activators |
07/24/2003 | US20030139425 Piperazine derivatives and their use as anti-inflammatory agents |
07/24/2003 | US20030139423 Central nervous system disorders; psychological disorders |
07/24/2003 | US20030139421 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain |
07/24/2003 | US20030139419 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
07/24/2003 | US20030139402 Antiinflammatory agents; Alzheimer's disease; cardiovascular disorders |
07/24/2003 | US20030138376 A compressed tablets comprising an embedded polymer matrix, insoluble and disintegrable in the solvents, removed by filtration, separation from a formed soluble product |
07/24/2003 | CA2473374A1 Phenyl sulfoxides and phenyl sulfones |
07/24/2003 | CA2471562A1 Tyrosyl derivatives and their use as p2x7 receptor modulators |